comparemela.com

Latest Breaking News On - Clinical trial notification - Page 6 : comparemela.com

Invex Therapeutics approved to start Presendin phase three clinical trial in Australia

Clinical-stage biopharmaceutical company Invex Therapeutics (ASX: IXC) has been given the green light to start its EVOLVE phase three clinical trial in Australia on patients with idiopathic intracranial hypertension (IIH).

Skye Bioscience Receives Australian Ethics Committee Approval to Start First-in-Human Phase 1 Study of SBI-100 Ophthalmic Emulsion

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.